Xipamide

CAS No. 14293-44-8

Xipamide( Diurexan | Aquaphor )

Catalog No. M26867 CAS No. 14293-44-8

Xipamide is a sulfonamide-based diuretic with antihypertensive properties. Xipamide selectively inhibits anion exchanger.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 31 In Stock
25MG 59 In Stock
50MG 91 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Xipamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Xipamide is a sulfonamide-based diuretic with antihypertensive properties. Xipamide selectively inhibits anion exchanger.
  • Description
    Xipamide is a sulfonamide-based diuretic with antihypertensive properties. Xipamide selectively inhibits anion exchanger.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Diurexan | Aquaphor
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CB1| GABAB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14293-44-8
  • Formula Weight
    354.81
  • Molecular Formula
    C15H15ClN2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (704.60 mM)
  • SMILES
    Cc1cccc(C)c1NC(=O)c1cc(c(Cl)cc1O)S(N)(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Francesca Ferlenghi, et al. The GABA B receptor positive allosteric modulator COR659: In vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives. Eur J Pharm Sci. 2020 Dec 1;155:105544.
molnova catalog
related products
  • Nardosinonediol

    Nardosinonediol shows cytotoxic activity against P-388 cells.

  • Kankanoside E

    Kankanoside E

  • Multinoside A

    Multinoside A (compound 6) is an antioxidant with DPPH free radical scavenging activity (IC50=54.3 μg/mL). Multinoside A can also downregulate COX-2 expression (IC50=9.6 μg/mL) and inhibit NO production (IC50=43.9 μg/mL).